相关实验视频

Updated: Jul 19, 2026

Peptide:MHC Tetramer-based Enrichment of Epitope-specific T cells

Peptide:MHC Tetramer-based Enrichment of Epitope-specific T cells

Published on: October 22, 2012

IMPROVE:一种特征模型,通过对T细胞识别的广泛验证来预测新表皮细胞免疫性

Annie Borch¹, Ibel Carri², Birkir Reynisson¹

¹Department of Health Technology, Technical University of Denmark, Lyngby, Denmark.

Frontiers in immunology

|April 18, 2024

概括

预测neoepitope免疫性对于癌症免疫疗法至关重要. 一个新的随机森林模型,IMPROVE,通过分析特征,准确地识别T细胞识别的新表位,改进患者特定的准策略.

科学领域:

免疫学免疫学免疫学
计算生物学计算生物学
在瘤学瘤学.

背景情况:

突变衍生的新抗原是癌症免疫治疗的关键标.
需要改进的新表位物识别和预测工具,以有效地针对新表位物.
由于数据稀缺,当前的计算工具在预测T细胞识别方面面临局限性.

研究的目的:

开发一个预测模型的新表位细胞免疫性.
加强针对癌症免疫治疗的患者特异性新抗原的识别.

主要方法:

利用了来自70名癌症患者的17,500个经过实验验证的新位候选人的数据集.
评估了27种不同的新进位特征.
开发了一种名为IMPROVE的随机森林模型,用于预测新位免疫性.

主要成果:

与现有方法相比,IMPROVE模型显著提升了新位标识.
在结核中的疏水和芳香残留被确定为预测免疫性质的关键特征.
该模型表现出提高预测T细胞对新表位细胞的识别能力.

结论:

IMPROVE模型在预测新表位细胞免疫性方面取得了重大进展.
准确地预测新表位细胞增强了成功癌症免疫疗法策略的潜力.
这项工作为选择强效的新抗原用于治疗开发提供了有价值的工具.

关键词:

免疫信息学是一种免疫信息学.免疫疗法免疫疗法机器学习是机器学习.新抗原是一种新抗原.新表位预测的预测.

更多相关视频

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Published on: November 17, 2018

相关概念视频

Cross-reactivity

Cross-reactivity

T Cell Activation and Clonal Selection

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...